Several considerations in using traditional Chinese patent medicine for cerebral infarction / 中国结合医学杂志
Chinese journal of integrative medicine
;
(12): 571-574, 2012.
Article
in English
| WPRIM
| ID: wpr-347151
ABSTRACT
Nowadays, a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world, several problems can be identified ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation, a lack of appropriate dosage and usage based on individual patient conditions, and a shortage of evidence from randomized, double-blind, placebo-controlled clinical trials. Furthermore, in terms of evaluation of the TCPM effectiveness, few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Patents as Topic
/
Drugs, Chinese Herbal
/
Cerebral Infarction
/
Therapeutic Uses
/
Dose-Response Relationship, Drug
/
Drug Therapy
/
Medicine, Chinese Traditional
Type of study:
Controlled clinical trial
/
Diagnostic study
/
Prognostic study
Limits:
Animals
/
Humans
Language:
English
Journal:
Chinese journal of integrative medicine
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS